CNSWF vs. NOVO-B.CO
CNSWF (Constellation Software Inc) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. CNSWF operates in Software - Application (Technology), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, CNSWF returned 18.47%/yr vs 17.63%/yr for NOVO-B.CO. At a 0.12 correlation, their price movements are largely independent.
Performance
CNSWF vs. NOVO-B.CO - Performance Comparison
Loading charts...
Different Trading Currencies
CNSWF is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CNSWF achieves a -12.86% return, which is significantly lower than NOVO-B.CO's -10.15% return. Both investments have delivered pretty close results over the past 10 years, with CNSWF having a 18.47% annualized return and NOVO-B.CO not far behind at 17.63%.
CNSWF
- 1D
- -4.59%
- 1M
- 13.58%
- YTD
- -12.86%
- 6M
- -12.08%
- 1Y
- -41.18%
- 3Y*
- 0.56%
- 5Y*
- 7.55%
- 10Y*
- 18.47%
NOVO-B.CO
- 1D
- 1.53%
- 1M
- -5.28%
- YTD
- -10.15%
- 6M
- -8.95%
- 1Y
- -41.84%
- 3Y*
- 6.83%
- 5Y*
- 19.41%
- 10Y*
- 17.63%
CNSWF vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CNSWF Constellation Software Inc | -12.86% | -22.46% | 24.90% | 59.77% | -15.99% | 43.09% | 34.48% | 53.34% | 6.04% | 33.51% |
NOVO-B.CO Novo Nordisk A/S | -10.15% | -39.54% | -15.04% | 214.95% | 23.90% | 65.39% | 27.16% | 32.88% | -10.64% | 58.82% |
Correlation
The correlation between CNSWF and NOVO-B.CO is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNSWF vs. NOVO-B.CO — Risk / Return Rank
CNSWF
NOVO-B.CO
CNSWF vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Constellation Software Inc (CNSWF) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CNSWF | NOVO-B.CO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.25 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 0.88 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | -0.79 | +0.02 |
| Martin ratioReturn relative to average drawdown | -1.15 | -1.17 | +0.02 |
Loading charts...
Drawdowns
CNSWF vs. NOVO-B.CO - Drawdown Comparison
The maximum CNSWF drawdown since its inception was -55.25%, smaller than the maximum NOVO-B.CO drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for CNSWF and NOVO-B.CO.
Loading charts...
Drawdown Indicators
| CNSWF | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.25% | -74.86% | +19.61% |
Max Drawdown (1Y)Largest decline over 1 year | -55.12% | -54.48% | -0.64% |
Max Drawdown (3Y)Largest decline over 3 years | -55.25% | -74.86% | +19.61% |
Max Drawdown (5Y)Largest decline over 5 years | -55.25% | -74.86% | +19.61% |
Max Drawdown (10Y)Largest decline over 10 years | -55.25% | -74.86% | +19.61% |
Current DrawdownCurrent decline from peak | -43.59% | -67.88% | +24.29% |
Average DrawdownAverage peak-to-trough decline | -6.91% | -12.38% | +5.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.56% | 36.72% | -0.16% |
Volatility
CNSWF vs. NOVO-B.CO - Volatility Comparison
Constellation Software Inc (CNSWF) has a higher volatility of 13.88% compared to Novo Nordisk A/S (NOVO-B.CO) at 12.08%. This indicates that CNSWF's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CNSWF | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.88% | 12.08% | +1.80% |
Volatility (6M)Calculated over the trailing 6-month period | 34.02% | 40.71% | -6.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.50% | 55.70% | -14.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.11% | 58.93% | -28.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.94% | 45.48% | -16.54% |
Dividends
CNSWF vs. NOVO-B.CO - Dividend Comparison
CNSWF's dividend yield for the trailing twelve months is around 0.19%, less than NOVO-B.CO's 4.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CNSWF Constellation Software Inc | 0.19% | 0.17% | 0.13% | 0.16% | 0.26% | 0.22% | 0.41% | 0.41% | 0.63% | 0.83% | 1.76% | 0.96% |
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
CNSWF vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Constellation Software Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CNSWF and NOVO-B.CO have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CNSWF and NOVO-B.CO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer